Edit submissions

Innovation Awards

Home

PHM_3_2021

Jan. 5, 2024

Latest from Home

CDMO 2025 Outlook

CDMO sector looks to recovery in 2025 amid positive macro, industry trends

shutterstock_424978426

Key drugs losing patent protection in 2025

pm2411_hero854x480_coverstory

Going above and beyond

With a focus on CGT manufacturing, BioForge will be operational by 2027.

Pittsburgh’s biotech leap

pm2409_hero854x480_coverstory

Pharma’s new age of longevity

Notable 2024 FDA decisions

https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887

http://twitter.com/PharmaMfg

http://www.linkedin.com/groups?gid=1813799

Contact Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions

© 2025 Endeavor Business Media, LLC. All rights reserved.